Narashino, Japan

Takaya Nakagawa

This inventor holds 1 USPTO granted patent. Top assignee: Tec Project Services Corporation. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takaya Nakagawa. Retrieved from https://idiyas.com/inventor/takaya-nakagawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Takaya Nakagawa: Innovator in Virus Inactivation Technology

Introduction

Takaya Nakagawa is a notable inventor based in Narashino, Japan. He has made significant contributions to the field of pharmaceutical technology, particularly in the area of virus inactivation. His innovative approach has the potential to enhance the safety and efficacy of liquid drug substances.

Latest Patents

Takaya Nakagawa holds a patent for an "Apparatus for virus inactivation and sampling." This invention is designed for use in the purification process of liquid drug substances. The apparatus features a closed circulation line that includes an outlet port of a bag containing the liquid drug substance, a first line, sampling means, a second line equipped with a pH meter, and an inlet port of the bag. An acidic aqueous solution is circulated through this system to effectively inactivate viruses present in the liquid drug substance. He has 1 patent to his name.

Career Highlights

Nakagawa is currently employed at Tec Project Services Corporation, where he continues to develop innovative solutions in the pharmaceutical industry. His work focuses on improving the safety and quality of drug substances through advanced technology.

Collaborations

Some of his notable coworkers include Hiroshi Ito and Yoichi Kitsuta, who contribute to the collaborative efforts at Tec Project Services Corporation.

Conclusion

Takaya Nakagawa's contributions to virus inactivation technology represent a significant advancement in the pharmaceutical field. His innovative apparatus not only enhances the safety of liquid drug substances but also showcases the importance of continued research and development in this critical area.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…